Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 8/20 | 0.64 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.61 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.58 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19010937 | 0.91 | OPRD1 (0.64) | OPRD1NTSR1NMUR2NMUR1OPRM1 | |
| SCHEMBL11191224 | 0.89 | OPRD1 (0.75) | OPRD1NTSR1NMUR2NMUR1OPRM1 | |
| SCHEMBL30171303 | 0.89 | OPRD1 (0.73) | OPRD1NTSR1NMUR2NMUR1OPRM1 | |
| Analog Of Dynorphin A SCHEMBL27861937 | 0.89 | OPRD1 (0.75) | OPRD1NTSR1NMUR2NMUR1OPRM1 | |
| SCHEMBL30775521 | 0.86 | NTSR1 (0.68) | OPRD1NTSR1OPRM1OPRK1 | |
| SCHEMBL1421598 | 0.85 | NTSR1 (0.72) | OPRD1NTSR1OPRM1OPRK1 | |
| SCHEMBL1421525 | 0.85 | NTSR1 (0.72) | OPRD1NTSR1OPRM1OPRK1 | |
| SCHEMBL1421513 | 0.85 | NTSR1 (0.72) | OPRD1NTSR1OPRM1OPRK1 | |
| SCHEMBL1421888 | 0.85 | OPRD1 (0.69) | OPRD1NTSR1OPRM1OPRK1 | |
| SCHEMBL1421931 | 0.85 | OPRD1 (0.69) | OPRD1NTSR1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150079658-A1 | Activated Polyoxazolines and Conjugates and Compositions Comprising the Same | SERINA THERAPEUTICS INC (US) | 2015-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150079658-A1 | Activated Polyoxazolines and Conjugates and Compositions Comprising the Same | SPOP, PNKP, PAICS | OPRD1 826/4885NTSR1 4412/4885NMUR2 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.